Spotlight On Retinal Vein Occlusion
Retinal vein occlusion remains one of the most prevalent retinal vascular disorders encountered in clinical practice and a leading cause of vision loss worldwide. With strong associations to systemic conditions such as hypertension, diabetes, and glaucoma, timely diagnosis and optimal management are critical to improving outcomes.
That’s why Spotlight On Retinal Vein Occlusion provides current evidence, emerging data, and expert perspectives on practical tools that can directly inform patient care, from first presentation through long-term follow-up.
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Eye on Ocular HealthThe Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Strategies for Addressing Complications in Retinal Vein Occlusion
Eye on Ocular HealthStrategies for Addressing Complications in Retinal Vein Occlusion
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular HealthRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular HealthOCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Retinal Vein Occlusion as a Predictor of Stroke
Eye on Ocular HealthRetinal Vein Occlusion as a Predictor of Stroke
Anti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
Eye on Ocular HealthAnti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
- advertisement
- 11/28/2025
- 10/22/2025
- 09/29/2025
- 09/26/2025
- 09/25/2025
- 09/24/2025





















